Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Human Vaccines & Immunotherapeutics|April 5, 2018
Targeting interleukin-22 for cancer therapyAnamarija Markota, Stefan Endres, Sebastian KoboldJournal of Immunology (Baltimore, Md. : 1950)|November 13, 2015
IRAK1 Drives Intestinal Inflammation by Promoting the Generation of Effector Th Cells with Optimal Gut-Homing CapacityAlexander F Heiseke, Benjamin H Jeuk, Anamarija Markota, et al.Plos One|July 6, 2019
Comparison of iron-reduced and iron-supplemented semisynthetic diets in T cell transfer colitisAnamarija Markota, Rebecca Metzger, Alexander F Heiseke, et al.Proceedings of the National Academy of Sciences of the United States of America|November 19, 2017
Cancer cells induce interleukin-22 production from memory CD4<sup>+</sup> T cells via interleukin-1 to promote tumor growthCornelia Voigt, Peter May, Adrian Gottschlich, et al.Science Advances|June 22, 2019
Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasisXiao Liu, Junjian Li, Bruno Loureiro Cadilha, et al.Immunity|January 11, 2023
T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasisDaria Briukhovetska, Javier Suarez-Gosalvez, Cornelia Voigt, et al.Pageof 1